Security key
471871202
Jasper Therapeutics, Inc. - Voting Common Stock (JSPR)
CUSIP: 471871202
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Voting Common Stock
- Shares outstanding
- 27,779,583
- Total 13F shares
- 12,950,959
- Share change
- +12,456,253
- Total reported value
- $379,146,145
- Put/Call ratio
- 14%
- Reported price per share
- $29.36
- Number of holders
- 56
- Value change
- +$364,621,578
- Number of buys
- 55
- Number of sells
- 1
Security identity
2 facts
Holder snapshot
9 facts
Report period
Q1 2024
Institutions
56
Top holders
10
JSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Jasper Therapeutics, Inc. SEC filings
Jasper Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 471871202
Recent filing periods:
Ownership snapshot
Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Fernwood Investment Manag...
13D/G signal
—
Evidence rows
15
Latest as of
08 Feb 2024
13F
3/4/5
Lead comparable stake: 1.8%
Showing 1-6 of 15 holder rows.
Rank 1 holder
Fernwood Investment Management, LLC
13F
- Ownership
- 1.8%
- Position
- $390.3K
Rank 2 holder
Velan Capital Investment Management LP
3/4/5
13F
- Ownership
- —
- Position
- $18.57M
Rank 3 holder
Carlyle Group Inc.
3/4/5
13F
- Ownership
- —
- Position
- $13.81M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fernwood Investment Management, LLC |
13F
Company
|
1.8%
|
$390,323
494,706 shares
|
— | 31 Dec 2023 |
| Velan Capital Investment Management LP |
3/4/5
13F
10%+ Owner · Company
|
—
class O/S missing
|
$18,568,073
1,433,828 shares
|
— | 08 Feb 2024 |
| Carlyle Group Inc. |
3/4/5
13F
Former 10% Owner · Company
|
—
class O/S missing
|
$13,807,148
1,066,189 shares
|
— | 08 Feb 2024 |
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$5,525,844
8,519,648 shares
|
— | 27 Jan 2023 |
| ROCHE HOLDING LTD |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$2,950,874
4,549,606 shares
|
— | 25 Jan 2023 |
| Amplitude Healthcare Holdings LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,491,780
2,300,000 shares
|
— | 24 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
56
Shares
12,950,959
Rows available
56
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
1
Q1 2024 holders
56
Holder diff
55
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend